IMMULITE SYSTEMS PSA & THIRD GENERATION PSA REAGENTS
Siemens Healthcare Diagnostics, Inc. · Decision date Sep 15, 1995
What did the FDA approve?
FDA record P930027 shows a decision date of September 15, 1995, with the decision field reading "APPR." The statement field says "APPROVAL FOR THE COAT-A-COUNT PSA IRMA." The device category is "Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer," and the product code is MTF.
The title names IMMULITE SYSTEMS PSA & THIRD GENERATION PSA REAGENTS, while the statement names a different product, the COAT-A-COUNT PSA IRMA. The record does not state whether this was an original PMA or a supplement, because the supplement type and supplement reason fields are absent. No clinical effectiveness or safety conclusion is present in the source.
FDA approval order statement
APPROVAL FOR THE COAT-A-COUNT PSA IRMA
- Regulatory pathway
- Original PMA
- Clinical specialty
- Immunology
- Decision date
- Sep 15, 1995
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P930027
- Regulatory pathway
- Premarket approval application
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Product code
- MTF
- Decision code
- APPR
- Decision date
- Sep 15, 1995
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer.
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Product code
- MTF
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P930027 received
Application receipt date recorded by FDA.
P930027 · FDA decision
APPR
P930027/S041 · Related supplement
IMMULITE Systems PSA
Timeline entries are records held by MedtechLedger for P930027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P930027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
IMMULITE Systems PSAP930027/S041 | Siemens Healthcare Diagnostics, Inc. | PMA supplement | Sep 22, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Siemens Healthcare Diagnostics, Inc.
- Headquarters
- Not reported
- Brand website
- siemens-healthineers.com
- FDA applicant address
- Glyn Rhonwy, Llanberis, Gwynedd Ll55 4el, LL554EL
Sources and methodology
- Original FDA record: P930027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records